JUNB and chronic myelogenous leukemia, BCR-ABL1 positive: found that the down-regulation of JunB expression in advanced CML is not achieved through DNA methylation, which was suggested by the fact that JunB methylation was not observed in all CML cell lines studied, and only 3% of CML patients showed JunB methylation (Hoshino et al., 2009).